Lv31
220 积分 2024-05-28 加入
Transition from Hashimoto thyroiditis to Graves’s Disease: an unpredictable change?
3个月前
已完结
Is Incurred Sample Reanalysis (ISR) Applicable in Biomarker Assays?
4个月前
已完结
A Novel Neutralization Antibody Assay Method to Overcome Drug Interference with Better Compatibility with Acid-Sensitive Neutralizing Antibodies
4个月前
已完结
Assessment of the Immunogenicity Potential for Oligonucleotide-Based Drugs
4个月前
已完结
Overcoming Soluble Target Interference in Measurement of Total Bispecific Therapeutic Antibody Concentrations
5个月前
已完结
皖公网安备34019202002308
